Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cencora Inc.

286.64
+2.400.84%
Post-market: 286.700.0600+0.02%19:22 EDT
Volume:1.17M
Turnover:335.64M
Market Cap:55.56B
PE:33.38
High:288.08
Open:284.07
Low:284.07
Close:284.24
Loading ...

Cencora Inc (COR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com
·
06 Feb

Cencora price target raised to $270 from $260 at BofA

TIPRANKS
·
06 Feb

Evercore ISI Cuts Cencora Price Target to $280 From $285

MT Newswires Live
·
06 Feb

Cencora price target raised to $301 from $287 at Leerink

TIPRANKS
·
06 Feb

Cencora Q1 Earnings: Revenue And EPS Beat On Strong Push From Obesity Drugs, Specialty Medicines

Benzinga
·
06 Feb

BUZZ-Cencora rises after lifting 2025 profit forecast

Reuters
·
05 Feb

Cencora Shares up 3.2% After Co Raises 2025 Adj.profit Forecast

THOMSON REUTERS
·
05 Feb

Cencora Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
05 Feb

Cencora raises 2025 profit forecast on specialty drug demand

Reuters
·
05 Feb

Cencora Fiscal Q1 Adjusted Earnings, Revenue Increase

MT Newswires Live
·
05 Feb

Cencora increases FY25 adjusted EPS view to $15.25-$15.55 from $15.15-$15.45

TIPRANKS
·
05 Feb

Earnings Flash (COR) Cencora Posts Fiscal Q1 Revenue $81.49 Billion, vs. FactSet Est of $78.31 Billion

MT Newswires Live
·
05 Feb

Cencora Q1 2025 Adj EPS $3.73 Beats $3.50 Estimate, Sales $81.49B Beat $78.38B Estimate

Benzinga
·
05 Feb

Cencora Outlook Fiscal Year 2025 REV Growth to Be in the Range of 8 to 10 Percent on Non-Gaap Basis

THOMSON REUTERS
·
05 Feb

BRIEF-Cencora Q1 Adjusted EPS USD 3.73 Vs. IBES Estimate USD 3.5

Reuters
·
05 Feb

Cencora Reports Fiscal 2025 First Quarter Results

Business Wire
·
05 Feb

Cencora Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
05 Feb

What to Watch in the Day Ahead - Wednesday, February 5

Reuters
·
05 Feb

Why Cencora (COR) is a Top Value Stock for the Long-Term

Zacks
·
03 Feb

The Zacks Analyst Blog Highlights Amgen, Cencora, Humana and Ardent Health

Zacks
·
03 Feb